Historical shareholding details of DFA US Targeted Value Portfolio holdings in Allogene Therapeutics Inc (ALLO)

Monthly changes of DFA US Targeted Value Portfolio shareholding in Allogene Therapeutics Inc over the previous months

Month	Name	Total no. shares held	Percent Holding
Month	Name	Total no. shares held	Percent Holding
Jan 31, 2025	Dfa Us Targeted Value Portfolio	532,554	0.25%

Dec 31, 2024	Dfa Us Targeted Value Portfolio	532,554	0.25%

Nov 30, 2024	Dfa Us Targeted Value Portfolio	430,353	0.21%

Oct 31, 2024	Dfa Us Targeted Value Portfolio	430,353	0.21%

Sep 30, 2024	Dfa Us Targeted Value Portfolio	430,353	0.21%

Aug 31, 2024	Dfa Us Targeted Value Portfolio	430,353	0.21%

Jul 31, 2024	Dfa Us Targeted Value Portfolio	430,353	0.21%

Jun 30, 2024	Dfa Us Targeted Value Portfolio	430,353	0.21%

May 31, 2024	Dfa Us Targeted Value Portfolio	430,353	0.21%

Apr 30, 2024	Dfa Us Targeted Value Portfolio	394,003	0.19%

Mar 31, 2024	Dfa Us Targeted Value Portfolio	387,879	0.19%

Feb 29, 2024	Dfa Us Targeted Value Portfolio	209,441	0.12%

Jan 31, 2024	Dfa Us Targeted Value Portfolio	107,547	0.06%

Dec 31, 2023	Dfa Us Targeted Value Portfolio	107,547	0.06%

Oct 31, 2023	Dfa Us Targeted Value Portfolio	107,547	0.06%

Sep 30, 2023	Dfa Us Targeted Value Portfolio	275,768	0.16%

Jul 31, 2023	Dfa Us Targeted Value Portfolio	212,068	0.13%

Jun 30, 2023	Dfa Us Targeted Value Portfolio	101,158	0.06%

Apr 30, 2023	Dfa Us Targeted Value Portfolio	101,158	0.07%